<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR57">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>MC</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>YN</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>EJ</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>JS</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>YM</given-names>
   </name>
   <name>
    <surname>Hwang</surname>
    <given-names>HS</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>BM</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>YJ</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>JG</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>HM</given-names>
   </name>
   <name>
    <surname>Quan</surname>
    <given-names>FS</given-names>
   </name>
   <name>
    <surname>Compans</surname>
    <given-names>RW</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>SM</given-names>
   </name>
  </person-group>
  <article-title>Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection</article-title>
  <source>Molecular therapy : the journal of the American Society of Gene Therapy</source>
  <year>2014</year>
  <volume>22</volume>
  <issue>7</issue>
  <fpage>1364</fpage>
  <lpage>1374</lpage>
  <pub-id pub-id-type="doi">10.1038/mt.2014.33</pub-id>
  <pub-id pub-id-type="pmid">24590045</pub-id>
 </element-citation>
</ref>
